Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omar Alghazo

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
BJU International|October 30, 2019
Novel agents for metastatic hormone-sensitive prostate cancer - a practice guide for urologistsIsaac A Thangasamy, Edmond M Kwan, Jiasian Teh, et al.
The Journal of Urology|October 6, 2020
Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?Luis Ribeiro, Thomas Stonier, Luke Stroman, et al.
European Urology|November 5, 2019
Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysisNiranjan J Sathianathen, Samantha Koschel, Isaac A Thangasamy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2022
The PRIMARY Score: Using Intraprostatic <sup>68</sup>Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer DiagnosisLouise Emmett, Nathan Papa, James Buteau, et al.
European Urology Focus|November 11, 2020
Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of <sup>177</sup>Lu-PSMA-617 Prior to ProstatectomyNattakorn Dhiantravan, John Violet, Renu Eapen, et al.
European Urology Open Science|July 13, 2023
A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate BiopsyBrian D Kelly, Gideon Ptasznik, Matthew J Roberts, et al.
European Urology|October 27, 2023
Administering [<sup>177</sup>Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 StudyRenu S Eapen, James P Buteau, Price Jackson, et al.
European Urology|September 1, 2021
The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre StudyLouise Emmett, James Buteau, Nathan Papa, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BJU International|October 30, 2019
Novel agents for metastatic hormone-sensitive prostate cancer - a practice guide for urologistsIsaac A Thangasamy, Edmond M Kwan, Jiasian Teh, et al.
The Journal of Urology|October 6, 2020
Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?Luis Ribeiro, Thomas Stonier, Luke Stroman, et al.
European Urology|November 5, 2019
Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysisNiranjan J Sathianathen, Samantha Koschel, Isaac A Thangasamy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2022
The PRIMARY Score: Using Intraprostatic <sup>68</sup>Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer DiagnosisLouise Emmett, Nathan Papa, James Buteau, et al.
European Urology Focus|November 11, 2020
Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of <sup>177</sup>Lu-PSMA-617 Prior to ProstatectomyNattakorn Dhiantravan, John Violet, Renu Eapen, et al.
European Urology Open Science|July 13, 2023
A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate BiopsyBrian D Kelly, Gideon Ptasznik, Matthew J Roberts, et al.
European Urology|October 27, 2023
Administering [<sup>177</sup>Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 StudyRenu S Eapen, James P Buteau, Price Jackson, et al.
European Urology|September 1, 2021
The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre StudyLouise Emmett, James Buteau, Nathan Papa, et al.
Pageof 2